Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
35
ALLY Quote, Financials, Valuation and Earnings
Last price:
$35.00
Seasonality move
:
3.76%
Day range:
$34.62 - $35.53
52-week range:
$29.52 - $45.46
Dividend yield:
3.43%
P/E ratio:
25.74x
P/S ratio:
1.28x
P/B ratio:
0.90x
Volume:
23.9M
Avg. volume:
4.2M
1-year change:
-8.62%
Market cap:
$10.8B
Revenue:
$8.9B
EPS (TTM):
$1.36
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.5B | $8.8B | $9.2B | $9.1B | $8.9B | |
| Revenue Growth (YoY) | 2.23% | 17.41% | 5.24% | -1.84% | -1.91% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4B | $2.7B | $3.2B | $3.3B | $3.3B | |
| Other Inc / (Exp) | $406M | $427M | -$252M | $134M | $66M | |
| Operating Expenses | $3.3B | $3.3B | $4.3B | $4.2B | $4.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.4B | $3.9B | $2.3B | $1.1B | $836M | |
| Earnings of Discontinued Ops. | -$1M | -$5M | -$1M | -$2M | -$1M | |
| Income Tax Expense | $328M | $790M | $627M | $144M | $167M | |
| Net Income to Company | $1.1B | $3.1B | $1.7B | $957M | $668M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $3.1B | $1.7B | $957M | $668M | |
| Basic EPS (Cont. Ops) | $2.89 | $8.28 | $5.06 | $2.79 | $1.82 | |
| Diluted EPS (Cont. Ops) | $2.88 | $8.22 | $5.03 | $2.77 | $1.80 | |
| Weighted Average Basic Share | $375.6M | $362.6M | $316.7M | $303.8M | $306.9M | |
| Weighted Average Diluted Share | $377.1M | $365.2M | $318.6M | $305.1M | $310.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4.7B | $5.8B | $5.2B | $8B | $8.3B | |
| Revenue (Reported) | $7.5B | $8.8B | $9.2B | $9.1B | $8.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4.7B | $5.8B | $5.2B | $8B | $8.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.3B | $2.3B | $2.2B | $1.8B | |
| Revenue Growth (YoY) | 25.65% | 11.74% | 0.52% | -6.23% | -20.16% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $635M | $772M | $860M | $865M | $888M | |
| Other Inc / (Exp) | $127M | $4M | $63M | $29M | -$499M | |
| Operating Expenses | $838M | $1B | $1.1B | $1.1B | $889M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1B | $846M | $388M | $183M | -$284M | |
| Earnings of Discontinued Ops. | -- | -- | -$1M | -- | -- | |
| Income Tax Expense | $211M | $191M | $68M | $40M | -$59M | |
| Net Income to Company | $796M | $655M | $319M | $143M | -$225M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $796M | $655M | $319M | $143M | -$225M | |
| Basic EPS (Cont. Ops) | $2.12 | $1.87 | $0.96 | $0.38 | -$0.82 | |
| Diluted EPS (Cont. Ops) | $2.11 | $1.86 | $0.96 | $0.38 | -$0.82 | |
| Weighted Average Basic Share | $375.2M | $335.7M | $302.7M | $306M | $309M | |
| Weighted Average Diluted Share | $377.5M | $337.8M | $303.4M | $308.4M | $309M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.6B | $1.2B | $1.8B | $2.1B | $1.4B | |
| Revenue (Reported) | $2.1B | $2.3B | $2.3B | $2.2B | $1.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.6B | $1.2B | $1.8B | $2.1B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.9B | $9B | $9.3B | $8.9B | $8.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.5B | $2.8B | $3.2B | $3.3B | $3.3B | |
| Other Inc / (Exp) | $612M | $304M | -$193M | $100M | -$464M | |
| Operating Expenses | $3.2B | $3.5B | $4.4B | $4.3B | $4.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.8B | $3.7B | $1.9B | $898M | $381M | |
| Earnings of Discontinued Ops. | -$1M | -$5M | -$2M | -$1M | -$1M | |
| Income Tax Expense | $631M | $770M | $504M | $116M | $94M | |
| Net Income to Company | $2.2B | $2.9B | $1.4B | $781M | $300M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.2B | $2.9B | $1.4B | $781M | $286M | |
| Basic EPS (Cont. Ops) | $5.86 | $8.00 | $4.08 | $2.41 | $1.38 | |
| Diluted EPS (Cont. Ops) | $5.83 | $7.95 | $4.07 | $2.41 | $1.36 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.7B | $5.5B | $5.8B | $8.3B | $7.6B | |
| Revenue (Reported) | $7.9B | $9B | $9.3B | $8.9B | $8.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.7B | $5.5B | $5.8B | $8.3B | $7.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.3B | $2.3B | $2.2B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $635M | $772M | $860M | $865M | $888M | |
| Other Inc / (Exp) | $127M | $4M | $63M | $29M | -$499M | |
| Operating Expenses | $838M | $1B | $1.1B | $1.1B | $889M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1B | $846M | $388M | $183M | -$284M | |
| Earnings of Discontinued Ops. | -- | -- | -$1M | -- | -- | |
| Income Tax Expense | $211M | $191M | $68M | $40M | -$59M | |
| Net Income to Company | $796M | $655M | $319M | $143M | -$225M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $796M | $655M | $319M | $143M | -$225M | |
| Basic EPS (Cont. Ops) | $2.12 | $1.87 | $0.96 | $0.38 | -$0.82 | |
| Diluted EPS (Cont. Ops) | $2.11 | $1.86 | $0.96 | $0.38 | -$0.82 | |
| Weighted Average Basic Share | $375.2M | $335.7M | $302.7M | $306M | $309M | |
| Weighted Average Diluted Share | $377.5M | $337.8M | $303.4M | $308.4M | $309M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.6B | $1.2B | $1.8B | $2.1B | $1.4B | |
| Revenue (Reported) | $2.1B | $2.3B | $2.3B | $2.2B | $1.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.6B | $1.2B | $1.8B | $2.1B | $1.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.6B | $5.1B | $5.6B | $6.9B | $10.3B | |
| Short Term Investments | $29.7B | $33.4B | $25.6B | $19.7B | $19B | |
| Accounts Receivable, Net | $704M | $600M | $786M | $935M | $929M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $46.2B | $39.2B | $32.2B | $27.8B | $30.5B | |
| Property Plant And Equipment | $10.5B | $12.2B | $11.8B | $10.5B | $9.3B | |
| Long-Term Investments | $34.3B | $38.5B | $30.4B | $28.6B | $27.8B | |
| Goodwill | $343M | $822M | $822M | $669M | $551M | |
| Other Intangibles | $50M | $129M | $98M | $73M | $54M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $182.2B | $182.1B | $191.8B | $196.3B | $191.8B | |
| Accounts Payable | $1B | $794M | $843M | $1.4B | $1.4B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $1.9B | $2.6B | $1.6B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.2B | $794M | $3.2B | $4.7B | $3B | |
| Long-Term Debt | $22B | $17B | $17.8B | $17.6B | $17.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $167.5B | $165.1B | $179B | $182.6B | $177.9B | |
| Common Stock | $21.5B | $24B | $24.1B | $24.3B | $24.5B | |
| Other Common Equity Adj | -- | -$158M | -$4.1B | -$3.8B | -$3.9B | |
| Common Equity | $14.7B | $14.7B | $10.5B | $11.4B | $11.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $14.7B | $17.1B | $12.9B | $13.7B | $13.9B | |
| Total Liabilities and Equity | $182.2B | $182.1B | $191.8B | $196.3B | $191.8B | |
| Cash and Short Terms | $45.3B | $38.4B | $31.2B | $26.7B | $29.3B | |
| Total Debt | $24.1B | $17B | $19.7B | $20.1B | $19.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.8B | $3.9B | $9.8B | $8.2B | $10.4B | |
| Short Term Investments | $33.3B | $33.2B | $24.6B | $20B | $18.1B | |
| Accounts Receivable, Net | $608M | $609M | $807M | $941M | $889M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $50.2B | $38B | $35.3B | $29.3B | $31.2B | |
| Property Plant And Equipment | $10.9B | $12B | $11.6B | $10.1B | $9.2B | |
| Long-Term Investments | $37.9B | $38.2B | $29.4B | $28.7B | $27.4B | |
| Goodwill | $343M | $822M | $822M | $669M | $190M | |
| Other Intangibles | $46M | $121M | $91M | $67M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $181.9B | $184.3B | $196.2B | $192.9B | $193.3B | |
| Accounts Payable | $1.4B | $1.1B | $1.3B | $1.6B | $2.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $8.1B | $5.6B | $4.6B | $2.5B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.4B | $9.2B | $7.7B | $6.2B | $5.5B | |
| Long-Term Debt | $20.5B | $11.7B | $15.6B | $12.4B | $16.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $167.3B | $168.9B | $182.8B | $179.2B | $179.1B | |
| Common Stock | $21.6B | $24.1B | $24.2B | $24.4B | $24.5B | |
| Other Common Equity Adj | $27M | -$1.8B | -$3.8B | -$4B | -$3.3B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $14.6B | $15.4B | $13.4B | $13.7B | $14.2B | |
| Total Liabilities and Equity | $181.9B | $184.3B | $196.2B | $192.9B | $193.3B | |
| Cash and Short Terms | $49.1B | $37.1B | $34.3B | $28.2B | $28.6B | |
| Total Debt | $20.5B | $19.8B | $21.2B | $17B | $18.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $3.1B | $1.7B | $957M | $668M | |
| Depreciation & Amoritzation | $1.6B | $1.3B | $1.3B | $1.2B | $1.2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.7B | $4B | $6.2B | $4.6B | $4.5B | |
| Capital Expenditures | $4.3B | $5.1B | $3.5B | $2.8B | $3.5B | |
| Cash Acquisitions | -- | -$699M | -- | -- | $2B | |
| Cash From Investing | $8.4B | -$11.1B | -$17.3B | -$7.2B | $5B | |
| Dividends Paid (Ex Special Dividend) | -$289M | -$381M | -$494M | -$478M | -$482M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.7B | $3B | $7.1B | $5.7B | $4.3B | |
| Long-Term Debt Repaid | -$16.1B | -$6.5B | -$6.5B | -$4.6B | -$4.5B | |
| Repurchase of Common Stock | -$106M | -$4.7B | -$1.7B | -$33M | -$38M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $25M | -$3.8B | $11.6B | $3.8B | -$5.6B | |
| Beginning Cash (CF) | $4.4B | $16.6B | $5.7B | $6.2B | $7.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $12.2B | -$10.9B | $559M | $1.2B | $4B | |
| Ending Cash (CF) | $16.6B | $5.7B | $6.2B | $7.4B | $11.4B | |
| Levered Free Cash Flow | -$581M | -$1.1B | $2.7B | $1.8B | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $796M | $655M | $319M | $143M | -$225M | |
| Depreciation & Amoritzation | $373M | $339M | $317M | $310M | $361M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.2B | $1.6B | $1.4B | $1.3B | $940M | |
| Capital Expenditures | $1.3B | $946M | $741M | $709M | $819M | |
| Cash Acquisitions | -- | -- | -- | $1.9B | -- | |
| Cash From Investing | $452M | -$5.7B | -$382M | $3.6B | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -$73M | -$132M | -$124M | -$125M | -$128M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $56M | $1.1B | $3.1B | $123M | $24M | |
| Long-Term Debt Repaid | -$1.3B | -$2.2B | -$426M | -$699M | -$1.1B | |
| Repurchase of Common Stock | -$219M | -$584M | -$27M | -$29M | -$34M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.2B | $3B | $3.3B | -$3.6B | $438M | |
| Beginning Cash (CF) | $16.6B | $5.7B | $6.2B | $7.4B | $11.4B | |
| Foreign Exchange Rate Adjustment | $2M | $2M | -- | -$3M | -- | |
| Additions / Reductions | $455M | -$1.1B | $4.4B | $1.2B | $37M | |
| Ending Cash (CF) | $17B | $4.6B | $10.6B | $8.6B | $11.4B | |
| Levered Free Cash Flow | -$99M | $695M | $691M | $557M | $121M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2B | $2.9B | $1.4B | $781M | $300M | |
| Depreciation & Amoritzation | $1.5B | $1.2B | $1.3B | $1.2B | $1.3B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $4.1B | $4.5B | $6B | $4.4B | $4.2B | |
| Capital Expenditures | $4.5B | $4.8B | $3.3B | $2.7B | $3.6B | |
| Cash Acquisitions | -- | -- | -- | $1.9B | $7M | |
| Cash From Investing | $9.2B | -$17.2B | -$12B | -$3.2B | $74M | |
| Dividends Paid (Ex Special Dividend) | -$290M | -$440M | -$486M | -$479M | -$485M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.9B | $4B | $9.2B | $2.7B | $4.2B | |
| Long-Term Debt Repaid | -$13.5B | -$7.3B | -$4.7B | -$4.9B | -$4.9B | |
| Repurchase of Common Stock | -$221M | -$5.1B | -$1.1B | -$35M | -$43M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$3.3B | $306M | $11.9B | -$3.1B | -$1.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $10B | -$12.4B | $6B | -$2B | $2.8B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$356M | -$284M | $2.7B | $1.7B | $632M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $796M | $655M | $319M | $143M | -$225M | |
| Depreciation & Amoritzation | $373M | $339M | $317M | $310M | $361M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.2B | $1.6B | $1.4B | $1.3B | $940M | |
| Capital Expenditures | $1.3B | $946M | $741M | $709M | $819M | |
| Cash Acquisitions | -- | -- | -- | $1.9B | -- | |
| Cash From Investing | $452M | -$5.7B | -$382M | $3.6B | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -$73M | -$132M | -$124M | -$125M | -$128M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $56M | $1.1B | $3.1B | $123M | $24M | |
| Long-Term Debt Repaid | -$1.3B | -$2.2B | -$426M | -$699M | -$1.1B | |
| Repurchase of Common Stock | -$219M | -$584M | -$27M | -$29M | -$34M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.2B | $3B | $3.3B | -$3.6B | $438M | |
| Beginning Cash (CF) | $16.6B | $5.7B | $6.2B | $7.4B | $11.4B | |
| Foreign Exchange Rate Adjustment | $2M | $2M | -- | -$3M | -- | |
| Additions / Reductions | $455M | -$1.1B | $4.4B | $1.2B | $37M | |
| Ending Cash (CF) | $17B | $4.6B | $10.6B | $8.6B | $11.4B | |
| Levered Free Cash Flow | -$99M | $695M | $691M | $557M | $121M | |
Get ALLY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALLY
Sector
P/E ratio
25.74x
11.67x
PEG ratio
--
0.39x
P/B ratio
0.90x
1.05x
Price / LTM sales
1.28x
2.53x
Growth Metrics
ALLY
Sector
Revenue growth
-20.16%
5.04%
Earnings growth
62.5%
2.87%
Revenue (5-year growth)
3.99%
5.18%
Earnings forecast
$1.02
$0.56
Profitability
ALLY
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
0.89%
5.3%
Return on assets
0.15%
0.97%
Return on equity
2.03%
9.25%
Earnings Date
Last Earnings Date
Apr
17
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Jul
17
Balance Sheet
ALLY
Sector
Total cash
$28.6B
$470.2M
Short term investments
$19B
$233.7M
Total assets
$191.8B
$4B
Long term debt
$18.9B
$296.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
